Epax AS is a world leader in the omega-3 fatty acid concentrate field. The company offers a wide range of omega-3 concentrates
in the pharmaceutical as well as nutraceutical business-to-business segment.
The Epax AS group is headquartered in Oslo, Norway. Its principle production facility for nutraceutical ingredients in Ålesund,
Norway, is GMP certified for the manufacturing of Active Pharmaceutical Ingredients (API) by the Norwegian Medicines Agency.
In addition, Epax recently acquired the former Lundbeck manufacturing facility in Seal Sands, UK, to become the company’s
center for the manufacturing of pharmaceutical APIs.
EPAX products are individually formulated with varying EPA/DHA ratios and concentrations designed to target specific health concerns including
cardiovascular, cognitive, mood and mind, eye, joint, pre- and postnatal health, and to support a healthy inflammation response.
Click here to learn more about these health conditions.
Each EPAX
condition-specific formula is backed by years of clinical research, testing and validation. EPAX products have been used in more than 100 clinical studies.
We are committed to delivering products that are safe, pure and of a consistently high quality.
EPAX has a long
history of marine oil production to draw on and we are dedicated to constantly endeavouring to improve the purity and quality, as
well as the production and
purification technology of our products.
EPAX is the industry leader in terms of product purity. We have very strict
maximum limits for environmental pollutants as well as maximum limits for oxidation parameters.
